Product Information
LAMIVUDINE 10 MG/ML ORAL SOLN is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2176 per ML under NDC 65862005524. Its NADAC has been published 207 times since May 10, 2017.
Strength
10 mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862005524
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA077695On Market Since
11/21/2016
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 10 MG/ML ORAL SOLN has been published 207 times since May 10, 2017, and over the history we have for it it has declined 33.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2176 per ML |
|---|---|
| All-time high | $0.3251 (Mar 14, 2018) |
| All-time low | $0.2174 (Nov 20, 2024) |
| 52-week high | $0.2653 |
| 52-week low | $0.2176 |
| Median price | $0.2676 |
| Average price | $0.2714 |
| Largest weekly change | -14.7% (Nov 20, 2024) |
| Weeks tracked | 207 |
| Tracking since | May 10, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMIVUDINE 10 MG/ML ORAL SOLN?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 10 MG/ML ORAL SOLN, manufactured by Aurobindo Pharma Limited, is $0.2176 per ML (NDC 65862005524), effective Jun 24, 2026.
How has the price of LAMIVUDINE 10 MG/ML ORAL SOLN changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 10 MG/ML ORAL SOLN has declined 33.1%. It has been tracked across 207 weekly CMS publications since May 10, 2017.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 10 MG/ML ORAL SOLN?
Since May 10, 2017, the NADAC for LAMIVUDINE 10 MG/ML ORAL SOLN has ranged from a low of $0.2174 (Nov 20, 2024) to a high of $0.3251 (Mar 14, 2018), with a median of $0.2676 per ML.
Are there cheaper alternatives to LAMIVUDINE 10 MG/ML ORAL SOLN?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LAMIVUDINE 10 MG/ML ORAL SOLN, but none are currently priced below it.
Who manufactures LAMIVUDINE 10 MG/ML ORAL SOLN?
LAMIVUDINE 10 MG/ML ORAL SOLN (NDC 65862005524) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification